Treatment of splanchnic vein thrombosis (SVT) is a clinical challenge due to heterogeneity
of clinical presentations, increased bleeding risk, and lack of evidences from clinical trials.
We performed an international registry to describe current treatment strategies and factors
associated with therapeutic decisions in a large prospective cohort of unselected SVT
patients. A total of 613 patients were enrolled (mean age 53.1 years, standard
deviation±14.8); 62.6% males; the majority (468 patients) had portal vein thrombosis. Most …

Abstract Abstract 499 Background: Treatment of splanchnic vein thrombosis (SVT) is a
clinical challenge due to heterogeneity of clinical presentations, increased bleeding risk and
lack of evidences from clinical trials. We carried out an international registry aimed to
describe current treatment strategies and factors associated with therapeutic decisions in a
large prospective cohort of SVT patients. Methods: Between May 2008 and January 2012,
consecutive SVT patients were enrolled in the registry and information on clinical …